Scinai Immunotherapeutics's total assets for Q3 2024 were $12.26M, a decrease of -17.44% from the previous quarter. SCNI total liabilities were $2.26M for the fiscal quarter, a -89.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.